Skip to main content
Lancaster Resources Inc. logo

Lancaster Resources Inc. — Investor Relations & Filings

Ticker · LCR ISIN · CA51440M1023 CSE Mining and quarrying
Open in API
Filings indexed 334 across all filing types
Latest filing 2021-03-31 Regulatory Filings
Country CA Canada
Listing CSE LCR

About Lancaster Resources Inc.

https://lancaster-resources.com/

Lancaster Resources Inc. is a mineral exploration company dedicated to discovering and developing high-potential precious metal and critical mineral assets. The company focuses on gold, lithium, uranium, and polymetallic deposits across established mining jurisdictions, including North America and Australia. Key projects include the Lake Cargelligo Gold Project in New South Wales, Australia, and the Trans-Taiga Lithium Pegmatite Project and Lac Iris Polymetallic Property in Quebec. Lancaster emphasizes advancing projects responsibly with a commitment to sustainable environmental practices and long-term value creation.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Regulatory Filings
2021-03-31 English
Audited annual financial statements – English.pdf
Regulatory Filings
2021-03-31 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that the CEO of NeonMind Biosciences will speak at an upcoming industry conference. It discusses the company's drug development programs and provides background information about the company. There are no financial statements, no detailed financial performance data, no regulatory filings, no voting results, no management or board changes, no earnings data, and no mention of any report being attached or published. The content is primarily promotional and informational about an event and company activities. This type of document fits best into the category of a Regulatory Filing (RNS) as a general announcement that does not fit into any other specific category.
2021-03-30 English
News release - English.pdf
Regulatory Filings
2021-03-23 English
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 95% confidence The document is a notice regarding the upcoming Annual General & Special Meeting of NeonMind Biosciences Inc., including details such as meeting date, record dates, meeting location, and voting securities information. It does not contain financial statements, management discussion, or detailed report content. The document is short (1225 characters) and serves as an announcement of meeting logistics rather than the meeting materials or results. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly a notice related to the meeting. However, since it is a notice of meeting and record dates rather than voting results, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement about the meeting. Given the options, RNS is the most appropriate classification for this notice of meeting and record dates.
2021-03-20 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing NeonMind Biosciences' engagement with Certara to advance its synthetic psilocybin drug candidates for obesity. It discusses the company's drug development plans, intellectual property, and strategic partnerships. There are no financial statements, regulatory filings, voting results, or management changes. The content is primarily a corporate announcement about a business development initiative rather than a financial report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other specific categories.
2021-03-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.